SHIFT WORK DISORDER - myCME.com

Shift-work disorderContents and FacultyThe social and economicburden of shift-work disorder. . . . . . . . . . . . . . . . . . . . . . . . . . S3Larry Culpepper, md, mphDepartment of Family MedicineBoston University Medical CenterBoston, MassachusettsThe characterization and pathologyof circadian rhythm sleep disorders.. . . . . . . . . S12Christopher L. Drake, PhDHenry Ford HospitalSleep Disorders and Research CenterDetroit, MichiganRecognition of shift-workdisorder in primary care.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S18Jonathan R. L. Schwartz, MdUniversity of Oklahoma Health Sciences CenterINTEGRIS Sleep Disorders Center of OklahomaOklahoma City, OklahomaManaging the patientwith shift-work disorder. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S24Michael J. Thorpy, MdDirector of the Sleep-Wake Disorders CenterMontefiore Medical CenterBronx, New YorkDisclosuresDr Culpepper reports that he serves as a consultantto AstraZeneca, Eli Lilly and Company,Pfizer Inc, Wyeth, sanofi-aventis, and TakedaPharmaceuticals North America, Inc, and onthe speakers bureau of Wyeth.Dr Drake reports that he has received researchsupport from Cephalon, Inc., Takeda PharmaceuticalsNorth America, Inc, and Zeo, Inc.,and has served on the speakers bureaus ofCephalon, Inc., and as a consultant to sanofiaventis.Dr Schwartz reports that he serves as aconsultant to and on the speakers bureaus ofAstraZeneca, Boehringer Ingelheim Pharmaceuticals,Inc., Cephalon, Inc., Pfizer Inc,Sepracor Inc., Takeda Pharmaceuticals NorthAmerica, Inc, and GlaxoSmithKline.Dr Thorpy reports that he serves as aconsultant to and on the speakers bureaus ofCephalon, Inc., and Jazz Pharmaceuticals, Inc.SupportSupport for the publication of this supplementwas provided by Cephalon, Inc. Editorial assistancewas provided by Anthemis ConsultingLtd and supported by Cephalon, Inc.DisclaimerThe opinions expressed herein are those ofthe authors and do not necessarily representthose of Cephalon, Inc., or the publishers. Anyprocedures, medications, or other courses ofdiagnosis or treatment discussed or suggestedby the authors should not be used byclinicians without evaluation of their patients’conditions and possible contraindicationsor dangers in use, review of any applicablemanufacturer’s product information, and comparisonswith the recommendations of otherauthorities. Content may include productinformation that is inconsistent with or outsidethe approved labeling for these productsin the United States. Before prescribing anymedication, you must familiarize yourself withthe manufacturer’s product information.This material was submitted by AnthemisConsulting Ltd on behalf of the authors. It hasbeen edited and peer reviewed by The Journalof Family Practice.Cover Image © Linda FrichtelCopyright © 2010 Dowden Health MediaS January 2010 / Vol 59, No 1 • Supplement to The Journal of Family Practice